Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers

Hereditary Cancer in Clinical Practice

Volumn 12, Issue 1, 2014, Pages

  Hooker, Gillian W ^b   King, Lesley ^c   VanHusen, Lauren ^a   Graves, Kristi ^a   Peshkin, Beth N ^a   Isaacs, Claudine ^a   Taylor, Kathryn L ^a   Poggi, Elizabeth ^a   Schwartz, Marc D ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

BRCA1 2; Decision making; Quality of life; Satisfaction

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ANXIETY; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SURGERY; CANCER THERAPY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL DECISION MAKING; OVARIECTOMY; OVARY CANCER; PATIENT SATISFACTION; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RISK REDUCTION; SECOND DEGREE RELATIVE;

EID: 84897935366     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-12-9     Document Type: Article

References (36)

1. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007, 25(11):1329-1333. 10.1200/JCO.2006.09.1066, 2267287, 17416853.
2. Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, Krontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TL, Williams C, Yaneeklov T. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009, 7(10):1060-1096.
3. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS, Russell CA, and the American Cancer Society Breast Cancer Advisory Group American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57(2):75-89. 10.3322/canjclin.57.2.75, 17392385, and the American Cancer Society Breast Cancer Advisory Group.
4. Schwartz MD, Isaacs C, Graves KD, Poggi E, Peshkin BN, Gell C, Finch C, Kelly S, Taylor KL, Perley L. Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer 2012, 118(2):510-517. 10.1002/cncr.26294, 3286617, 21717445.
5. Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, Lawrence W, Main D, Finch C, Magnant C, Pennanen M, Tsangaris T, Wiley S, Isaacs C. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 2004, 22(10):1823-1829. 10.1200/JCO.2004.04.086, 15067026.
6. Beattie MS, Crawford B, Lin F, Vittinghoff E, Ziegler J. Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers. Genet Test Mol Biomarkers 2009, 13(1):51-56. 10.1089/gtmb.2008.0067, 2981359, 19309274.
7. Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manouklan S, Couch F, Sun P, Narod S. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 2008, 122(9):2017-2022. 10.1002/ijc.23340, 2936778, 18196574.
8. Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manouklan S, Moller P, Sun P, Narod S, Tung N, Gronwald J, Cummings S, Wagner T, Manouklan S, Moller P, Sun P, Narod S. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 2008, 26(7):1093-1097. 10.1200/JCO.2007.12.6078, 18195327.
9. Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, Brain A, Hopwood P, Howell A. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomarkers Prev 2009, 18(8):2318-2324. 10.1158/1055-9965.EPI-09-0171, 19661091.
10. Graves KD, Peshkin BN, Halbert CH, DeMarco TA, Isaacs C, Schwartz MD. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat 2007, 104(3):321-329. 10.1007/s10549-006-9423-5, 3060055, 17066320.
11. Geiger AM, West CN, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, Rolnick SJ, Harris EL, Greene SM, Elmore JG, Emmons KM, Fletcher SW. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol 2006, 24(9):1350-1356. 10.1200/JCO.2005.01.9901, 16549829.
12. Geiger AM, Nekhlyudov L, Herrinton LJ, Rolnick SJ, Greene SM, West CN, Harris EL, Elmore JG, Altschuler A, Liu IL, Fletcher SW, Emmons KM. Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol 2007, 14(2):686-694. 10.1245/s10434-006-9206-6, 17103066.
13. Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE, Petty PM, Johnson JL, Sitta DL, McDonnell SK, Rummans TA, Jenkins RB, Sloan JA, Hartmann LC. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 2000, 284(3):319-324. 10.1001/jama.284.3.319, 10891963.
14. Metcalfe KA, Esplen MJ, Goel V, Narod SA. Predictors of quality of life in women with a bilateral prophylactic mastectomy. Breast J 2005, 11(1):65-69. 10.1111/j.1075-122X.2005.21546.x, 15647082.
15. Westin SN, Sun CC, Lu KH, Schmeler KM, Soliman PT, Lacour RA, Johnson KG, Daniels MS, Arun BK, Peterson SK, Bodurka DC. Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer 2011, 117(12):2659-2667. 10.1002/cncr.25820, 21656744.
16. Metcalfe KA, Esplen MJ, Goel V, Narod SA. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psychooncology 2004, 13(1):14-25. 10.1002/pon.726, 14745742.
17. Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, Putten H, Velden K, Boonstra H, Aaronson NK. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005, 23(28):6890-6898. 10.1200/JCO.2005.02.626, 16129845.
18. Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol 2009, 112(3):594-600. 10.1016/j.ygyno.2008.11.039, 2697574, 19141360.
19. Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, Linden A, von Wachenfeldt A, Wickman M, Arver B. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 2008, 26(24):3943-3949. 10.1200/JCO.2007.13.9568, 18711183.
20. Tercyak KP, Peshkin BN, Brogan BM, DeMarco T, Pennanen MF, Willey SC, Magnant CM, Rogers S, Isaacs C, Schwartz MD. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. J Clin Oncol 2007, 25(3):285-291. 10.1200/JCO.2006.07.3890, 17159191.
21. Isern AE, Tengrup I, Loman N, Olsson H, Ringberg A. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction. J Plast Reconstr Aesthet Surg 2008, 61(10):1177-1187. 10.1016/j.bjps.2007.08.006, 17938010.
22. Graves KD, Vegella P, Poggi EA, Peshkin BN, Tong A, Isaacs C, Finch C, Kelly S, Taylor KL, Luta G, Schwartz MD. Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiol Biomarkers Prev 2012, 21(3):445-455. 10.1158/1055-9965.EPI-11-0991, 3297701, 22328347.
23. Halbert CH, Stopfer JE, McDonald J, Weathers B, Collier A, Troxel AB, Domchek S. Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?. J Clin Oncol 2011, 29(32):4302-4306. 10.1200/JCO.2010.33.1561, 3221529, 21990416.
24. Schwartz MD. Contralateral prophylactic mastectomy: efficacy, satisfaction, and regret. J Clin Oncol 2005, 23(31):7777-7779. 10.1200/JCO.2005.08.903, 16204004.
25. Schwartz MD, Kaufman E, Peshkin BN, Isaacs C, Hughes C, DeMarco T, Finch C, Lerman C. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. J Clin Oncol 2003, 21(21):4034-4041. 10.1200/JCO.2003.01.088, 14581427.
26. Graves KD, Wenzel L, Schwartz MD, Luta G, Wileyto P, Narod S, Peshkin BN, Marcus A, Cella D, Emsbo SP, Barnes D, Hughes Halbert C. Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2010, 19(3):648-654. 10.1158/1055-9965.EPI-09-0548, 2849295, 20200423.
27. Schwartz MD, Valdimarsdottir HB, DeMarco TA, Peshkin BN, Lawrence W, Rispoli J, Brown K, Isaacs C, O'Neill S, Shelby R, Grumet SC, McGovern MM, Garnett S, Bremer H, Leeman S, O'Mara K, Kelleher S, Komaridis K. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychol 2009, 28(1):11-19. 3580845, 19210013.
28. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory 1983, Palo Alto, CA: Consulting Psychologists Press, Inc.
29. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983, 13(3):595-605. 10.1017/S0033291700048017, 6622612.
30. Holmes-Rovner M, Kroll J, Schmitt N, Rovner DR, Breer ML, Rothert ML, Padonu G, Talarczyk G. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996, 16(1):58-64. 10.1177/0272989X9601600114, 8717600.
31. Lantz PM, Janz N, Fagerlin A, Schwartz K, Liu L, Lakhani I, Salem B, Katz S. Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer. Health Serv Res 2005, 40(3):745-767. 10.1111/j.1475-6773.2005.00383.x, 1361166, 15960689.
32. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 1997, 15(3):974-986.
33. Metcalfe KA, Semple JL, Narod SA. Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study. Plast Reconstr Surg 2004, 114(2):360-366. 10.1097/01.PRS.0000131877.52740.0E, 15277800.
34. Frost MH, Hoskin TL, Hartmann LC, Degnim AC, Johnson JL, Boughey JC. Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits. Ann Surg Oncol 2011, 18(11):3110-3116. 10.1245/s10434-011-1917-7, 3964591, 21947589.
35. Robson M, Hensley M, Barakat R, Brown C, Chi D, Poynor E, Offit K. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol Oncol 2003, 89(2):281-287. 10.1016/S0090-8258(03)00072-6, 12713992.
36. Schwartz CE, Andresen EM, Nosek MA, Krahn GL, RRTC Expert Panel on Health Status Managment Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil 2007, 88(4):529-536. 10.1016/j.apmr.2006.12.032, 17398257, RRTC Expert Panel on Health Status Managment.